ATE399019T1 - Verwendungen von tgap7 zur modulation der aktivierung von leukozyten - Google Patents

Verwendungen von tgap7 zur modulation der aktivierung von leukozyten

Info

Publication number
ATE399019T1
ATE399019T1 AT01938157T AT01938157T ATE399019T1 AT E399019 T1 ATE399019 T1 AT E399019T1 AT 01938157 T AT01938157 T AT 01938157T AT 01938157 T AT01938157 T AT 01938157T AT E399019 T1 ATE399019 T1 AT E399019T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
tgap7
protein
furthermore
treatment
Prior art date
Application number
AT01938157T
Other languages
English (en)
Inventor
Nalan Utku
Mirko Schlawinsky
Original Assignee
Cellact Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellact Pharma Gmbh filed Critical Cellact Pharma Gmbh
Application granted granted Critical
Publication of ATE399019T1 publication Critical patent/ATE399019T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01938157T 2000-05-03 2001-05-03 Verwendungen von tgap7 zur modulation der aktivierung von leukozyten ATE399019T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00109462 2000-05-03

Publications (1)

Publication Number Publication Date
ATE399019T1 true ATE399019T1 (de) 2008-07-15

Family

ID=8168619

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01938157T ATE399019T1 (de) 2000-05-03 2001-05-03 Verwendungen von tgap7 zur modulation der aktivierung von leukozyten

Country Status (6)

Country Link
US (1) US20030166599A1 (de)
EP (1) EP1278535B1 (de)
AT (1) ATE399019T1 (de)
AU (1) AU2001263888A1 (de)
DE (1) DE60134545D1 (de)
WO (1) WO2001082948A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2421949A1 (en) * 2000-09-11 2002-03-21 Hyseq, Inc. Novel nucleic acids and polypeptides
EP2308892A1 (de) 2009-10-01 2011-04-13 Sanofi-Aventis Verwendung von siRNA gegen Sipa1l1 zur Reduzierung von Lipogenese

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4459435B2 (ja) * 1997-08-29 2010-04-28 ナラン ウトゥク 新規ｔ細胞膜蛋白質（ｔｉｒｃ７）、ペプチドおよびそれに由来する抗体ならびにその使用
US6440696B1 (en) * 1999-07-28 2002-08-27 New England Medical Center E6 targeted protein (E6TP1)

Also Published As

Publication number Publication date
US20030166599A1 (en) 2003-09-04
AU2001263888A1 (en) 2001-11-12
EP1278535A2 (de) 2003-01-29
DE60134545D1 (de) 2008-08-07
EP1278535B1 (de) 2008-06-25
WO2001082948A3 (en) 2002-05-23
WO2001082948A2 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
ATE485371T1 (de) Varianten des menschlichen koagulationsfaktors vii
ATE443161T1 (de) Mittel und verfahren für den nachweis von methylierter dna
ATE474048T1 (de) Her2/neu fusionsproteine
HUP0500345A2 (hu) Készítmények és alkalmazások tüdőrák kezelésére és diagnosztizálására
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
DE60144145D1 (de) Subtilisin-variante
PT1090033E (pt) Particulas de proteinas de envelope do hcv: utilizacao para vacinacao
DK43890D0 (da) Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse
WO2001068708A3 (en) Human and humanized fap-alpha-specific antibodies
BRPI0411363A (pt) seqüências de ácidos nucléicos codificando e composições compreendendo peptìdeo sinal ige e/ou il-15 e processos para uso das mesmas
DE60138558D1 (de) Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung
ATE232399T1 (de) Verfahren zur modulierung des wachstums kollateraler arterien und / oder anderer arterien aus bestehenden arteriolen verbindungen
AR042968A1 (es) Anticuerpos de virus anti-dengue composiciones metodos y usos
ATE449847T1 (de) Hepatitis c rezeptorprotein cd81
ATE384263T1 (de) Verfahren zur bestimmung von biologischen agenzien in lebenden zielzellen
FI20050753A (fi) Uudet peptidit
ATE399019T1 (de) Verwendungen von tgap7 zur modulation der aktivierung von leukozyten
EA200300132A1 (ru) Стресс-белки и пептиды и способы их применения
DE60122721D1 (de) Diagnostische verwendungen des t-zell proteins tzon7, der davon abgeleiteten peptide und des antikörpers
PT86944A (pt) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben
WO2004011496A3 (en) Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof
DE60229924D1 (de) Fusionsproteine zur spezifisichen behandlung von krebs und autoimmunkrankheiten
ATE305041T1 (de) Kompositionen und verwendungen von cgi-69
ATE463566T1 (de) Tumor- und seneszenzsmarker
KLEPPEL COMPARISON OF THE NC1 DOMAIN OF TYPE IV COLLAGEN ISOLATED FROM HUMAN GLOMERULAR BASEMENT MEMBRANES AND A MOUSE TUMOR (EHS)(GBM, GOODPASTURE ANTIGEN)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties